Pharmacodynamics of B-Cell Depletion and Pharmacokinetics of the Novel Anti-CD20 Monoclonal Antibody Ublituximab in Patients With Relapsing Multiple Sclerosis-MedSci.cn

Pharmacodynamics of B-Cell Depletion and Pharmacokinetics of the Novel Anti-CD20 Monoclonal Antibody Ublituximab in Patients With Relapsing Multiple Sclerosis

Fox, E; Steinman, L; Hartung, H; Alvarez, E; Qian, P; Wray, S; Robertson, D; Huang, D; Selmaj, K; Wynn, D; Weiss, MS; Bosco, JA; Power, SA; Mok, KA; Lee, L; Cree, BA

MULTIPLE SCLEROSIS JOURNAL, 2022; 28 (1_SUPPL): 68

科室
- - 订阅+
  - 更多科室
工具
服务